SpeedWeed

MAY 5, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

SpeedWeed

MAY 4, 2021

Last week was eventful for cannabis reform in Texas, as the House of Representatives approved three legislative proposals, which would expand the state’s medical cannabis program, reduce penalties for concentrates and decriminalize possession. 1535 would also raise the THC limit in medical cannabis from 0.5%

Programs 52

Programs Chronic Pain Concentrates THC 52

Cannabis Law Report

AUGUST 17, 2021

We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. A replay will be available on Marinus’ website approximately two hours after completion of the event and will be archived for up to 30 days. Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

MMJ Recs

MARCH 2, 2024

Insider Tips for Ohio Medical Marijuana Dispensary Visits Join loyalty programs and follow dispensaries on social media platforms to access exclusive promotions and discounts. A: Qualifying medical conditions in Ohio include cancer, PTSD, chronic pain, epilepsy, and more. Q: Can I purchase medical marijuana from any dispensary in Ohio?

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

JANUARY 13, 2020

In particular, we see significant market opportunity for nabiximols in several indications in the US and will be progressing multiple late stage clinical programs in 2020.”. Nabiximols (known as “Sativex” outside US) in the US: Commence pivotal clinical program in initial target indication of spasticity associated with Multiple Sclerosis.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

MMJ Recs

MARCH 25, 2022

Patient drives are like pop-up day events, during which many people can avail of quick and easy appointments for MMJ cards if they have a qualifying condition. There may be other qualifying conditions for a NY MMJ card. MMJ evaluation patient drives can be hugely beneficial for those seeking MMJ cards in New York.

Patients 52

Patients Conditions Chronic Pain Dispensary 52

Cannabis Law Report

MARCH 2, 2020

This renewed interest in psychedelics is being sparked by a pair of seemingly unrelated events. First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment). The dawn of a new era in psychedelic medicine. Potential IPOs within the next year.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Veriheal

OCTOBER 5, 2020

The Medical Marijuana Dispensary Program of Hawaii was created in order to get medical cannabis consumers to register for consuming the plant. The program requires cannabis patients to have a licensed physician to certify that the individual would benefit from medical cannabis before they can register for it.

Edibles 52

Edibles Legalization Decriminalization Consumption 52

The Cannigma

MAY 19, 2021

Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law 137

Law Legalization Clinical Trials CBD 137

The Joint Blog

MARCH 4, 2020

To become a medical cannabis patient an individual must suffeer from a specific medical condition, such as cancer, HIV, epilepsy, autism or multiple sclerosis, and receive approval from a state-appointed board of physicians. successful program here in Utah,” said Rigby. Dragonfly Wellness will be open seven days a week from 11 a.m.

Marijuana 29

Marijuana Epilepsy Conditions Events 29

MMJ Recs

OCTOBER 2, 2023

Since then, additional legislation and amendments have shaped the state’s medical marijuana program. Recreational vs. Qualifying Conditions for Medical Marijuana in California California’s medical marijuana program allows patients with certain qualifying conditions to access medical cannabis for therapeutic purposes.

Dispensary 52

Dispensary Patients Environment Conditions 52

Canna Law Blog

MAY 29, 2019

Accordingly, TSA security officers do not search for marijuana or other illegal drugs, but in the event a substance that appears to be marijuana or a cannabis infused product is observed during security screening, TSA will refer the matter to a law enforcement officer.”. Department of Agriculture.

Hemp 78

Hemp CBD Agriculture Policy 78

Canna Law Blog

JUNE 7, 2019

Under the 2014 Farm Bill, state departments of agriculture and universities could undertake agricultural pilot programs to permit the cultivation of hemp. At this point, we’ll talk about Washington State, where lawmakers have just overhauled the entire hemp program. Some states also license the processing of hemp.

Hemp 73

Hemp CBD Agriculture Food 73

Cannabis Law Report

SEPTEMBER 20, 2021

Missouri’s regulations provide for numerous qualifying medical conditions for treatment with cannabis, including, among others, cancer, epilepsy, PTSD, HIV/AIDS, terminal illness, Alzheimer’s and any chronic medical condition normally treated with prescription medication that can lead to dependence. IIP Contact: Catherine Hastings.

Cultivation 52

Cultivation Dispensary Patients Epilepsy 52

Cannabis Law Report

JUNE 1, 2021

Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program. The Company anticipates that subsequent events and developments will cause the Company’s views to change. About Sesen Bio. Sesen Bio, Inc.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Forward-looking statements speak only as of the date they are made.

Therapy 52

Therapy Research and Development Business Access 52

CannaMD

SEPTEMBER 15, 2020

Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. But in the event a substance appears to be marijuana or a cannabis-infused product, we’re required by federal law to notify law enforcement. Crohn’s Disease. Multiple Sclerosis.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

OCTOBER 24, 2019

It will allow for regulated, supervised and limited access for our sick citizens especially those with cancer, HIV/ AIDS, glaucoma, and epilepsy. Politicians are listening closely to the public discussions and consultations being raised at Cannabis educational events about how to move forward. The oils can be legally imported.

Law 45

Law Medicine Decriminalization Oil 45

Cannabis Law Report

FEBRUARY 18, 2020

The New York State Medical Marijuana Program defines a list of medical conditions and diseases that qualify patients to use medical cannabis. In the event you’re not approved for certification, the appointment fee will be returned. The physical certificate will arrive by mail 5-7 days after the appointment.

Marijuana 59

Marijuana Consumption Dispensary Vaping 59

Cannabis Law Report

JULY 26, 2021

The primary safety objective of the study will be to assess absolute and relative frequencies of Serious Adverse Events (SAEs) for the whole population and separately for SCI-110 and placebo groups. About SciSparc (OTCQB: SPRCY): SciSparc Ltd. Investor Contact: IR@scisparc.com. Tel: +972-3-6167055. [1] 1] [link]. [2] 2] [link]. [3]

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

The Cannigma

JANUARY 31, 2021

He said the organization also encourages members to take part in charity events (like 10k and 5k runs) that raise money and awareness for diseases that cannabis can potentially help treat, such as multiple sclerosis , cancer , and epilepsy. Is working out high easier? A woman trail running in the woods (thevisualsyouneed/123r).

THC 145

THC Cannabis Environment CBD 145

Cannabis Law Report

DECEMBER 20, 2021

Virpax recently acquired global rights to VRP324, a product candidate for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management of epilepsy in children (a rare pediatric disease) and adults. MET technology is also used in AnQlar™, a candidate to inhibit viral replication caused by influenza or SARS-CoV-2.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

AUGUST 2, 2021

Because such statements deal with future events and are based on SciSparc’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of SciSparc could differ materially from those described in or implied by the statements in this press release. Logo – [link].

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

SEPTEMBER 23, 2019

Department of Agriculture (USDA) Hemp Production Program, removing hemp from the Controlled Substances Act. Virgin Islands have a comprehensive, publicly-available medical marijuana/cannabis program, and 13 of these states have also removed jail time for possessing small amounts of non-medical marijuana. Hemp production program.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

NOVEMBER 15, 2021

Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. VRP324 represents our first CNS disorder product indication. For more information, please visit www.virpaxpharma.com.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

The Cannigma

MAY 7, 2021

Europe’s obviously come a long way and most of the countries on the continent have varying degrees of medical programs alongside going hemp industries but can you start by giving a quick overview of where Europe is in comparison to North America but also your thoughts on why the momentum seems to be different?

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

JANUARY 26, 2022

While commonly associated with traumatic events in combat or other military service, PTSD may also be initiated by abuse, neglect, accidents or natural disasters, significant loss, or other difficult experiences. Corine de Boer, M.D., Chief Medical Officer at MAPS PBC. ABOUT MAPS PUBLIC BENEFIT CORPORATION (MAPS PBC).

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

SMPL

MAY 26, 2020

We were talking about, ‘What can we do with this?’ ” recalled Samantha Miller, who hosted the event at her split-level house, wedged between redwoods and a creek below. In 2020, CBD is available three ways: over the counter; at state-licensed marijuana dispensaries; or if you have certain forms of epilepsy, from GW Pharmaceuticals.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

OCTOBER 11, 2021

The expansion of the Texas medical marijuana program is a sign that red state politicians understand the public’s shifting attitudes on marijuana. Starting in September 2021, state residents can enter the Texas medical marijuana program if they have cancer. 5 percent to 1 percent. The Future of Texas Medical Marijuana.

Patients 52

Patients Marijuana Chronic Pain Programs 52

The Cannigma

OCTOBER 8, 2021

The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. Medical: legal Recreational: Illegal. The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009.

Legalization 52

Legalization Medicine Conditions Patients 52

Veriheal

JULY 28, 2021

To qualify, patients must receive a diagnosis for one of the “debilitating” medical conditions featured in the bill; which include (but are not limited to) AIDS , ALS , cancer, epilepsy , multiple sclerosis (MS) , and post-traumatic stress disorder (PTSD).

Seed-To-Sale 59

Seed-To-Sale Research and Development Pharmaceutical Conditions 59

The Cannigma

DECEMBER 22, 2021

We have autism and epilepsy. I think anyone that gets into this business is, we get addicted to this, to the smart event where we’re working around the clock, there’s always something new. Because it’s not in the list and the doctors wants to give the prescription. It’s quite a large operation.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Veriheal

SEPTEMBER 22, 2021

As per the proposed bill, multiple sclerosis (MS), Parkinson’s disease , epilepsy , post-traumatic stress disorder (PTSD), and HIV/AIDS are some examples of medical conditions featured on the list of qualifying criteria. Up to 10 Medical Cannabis Suppliers Could Grow and Sell in North Carolina .

Legalization 111

Legalization Patients Cultivation Legislation 111

Canna Law Blog

NOVEMBER 16, 2021

In the event a Tribe or State doesn’t develop a plan or the plan is rejected by USDA, then growers will just follow the overall system put together by USDA (these directives are very similar to the standards set out in the 2018 Farm Bill, legalizing hemp). .

DEA 88

DEA Business Banking Food 88

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. This is true even if the CBD comes from industrial hemp.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. Continued Protections for State Legal Medical Programs.

Legislation 59

Legislation Patients Access Banking 59

MassRoots

NOVEMBER 19, 2018

At a CNN event in 2015 he said that while he’s “not a big fan of legalizing marijuana,” you can “count me in for medical marijuana” because he is “convinced that it helps people with epilepsy.”. In the 116th Congress, there will be at least 66 Senators representing states with a regulated medical cannabis program,” Strekal added.

Marijuana 56

Marijuana Policy Legislation Research and Development 56